Article Figures & Data
Tables
Recommendation Allograft Patient Population Standard practice postimplantation All recipients weekly All recipients with persistent DGF within 3 mo All highly sensitized/at-risk patients (unless clinical rejection has occurred) at time of detection Any recipient with significantly increased urine or plasma markers of PPV Strongly recommended 6 to 12 mo Recipients with high CNI exposure, H/O toxicity 6 to 12 mo Recipients with H/O prolonged DGF, rejection Recommended for study (with interventional trials) 1 to 3 mo All recipients 6 to 12 mo All recipients ↵ a DGF, delayed graft function; PPV, polyoma virus, CNI, calcineurin inhibitor; H/O, history of.